These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 5342108)
1. [Pyrithioxine (Encephabol); report of a double blind study of the action of pyrithioxine (Encephabol) in patients suffering from central deafness]. Nelemans FA Ned Tijdschr Geneeskd; 1966 Nov; 110(45):2002-5. PubMed ID: 5342108 [No Abstract] [Full Text] [Related]
2. [Pyrithioxine (encephabol). Report of a double-blind study]. Zelvelder WG Ned Tijdschr Geneeskd; 1965 Sep; 109(37):1734-6. PubMed ID: 5321500 [No Abstract] [Full Text] [Related]
3. Clinical trial of pyrithioxine (Encephabol). Naik BK; Satyanarayan Rao P; Saboo R; Parlay K Indian Pract; 1965 Oct; 18(10):737-41. PubMed ID: 5847446 [No Abstract] [Full Text] [Related]
4. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis]. Schlesinger P Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863 [No Abstract] [Full Text] [Related]
5. [Empirical report on the use of pyrithioxine in pediatric practice (with special reference to experience within the scope of educational advice)]. Bleckmann KH Prax Kinderpsychol Kinderpsychiatr; 1965; 14(8):316-7. PubMed ID: 5330393 [No Abstract] [Full Text] [Related]
6. [Pyrithioxine in the treatment of craniocerebral injuries]. Schreiber KG Landarzt; 1965 Sep; 41(26):1126-8. PubMed ID: 5325108 [No Abstract] [Full Text] [Related]
7. A placebo-controlled study of pyritinol ('Encephabol') in dementia. Cooper AJ; Magnus RV Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. Otomo E; Araki G; Mori A; Kurihara M Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354 [TBL] [Abstract][Full Text] [Related]
10. [Experiences with pyrithioxine in migraine]. Lemmens F Landarzt; 1965 Oct; 41(28):1228-9. PubMed ID: 5863958 [No Abstract] [Full Text] [Related]
11. [On therapeutic studies with pyrithioxine in migraine disorders]. Vodopivec M Praxis; 1965 Sep; 54(36):1051-4. PubMed ID: 5898384 [No Abstract] [Full Text] [Related]
12. [Betaserc (Betahistine-HC1) in the treatment of acute deafness]. Grahne B; Paavolainen M Med Monatsschr; 1976 Jun; 30(6):273-5. PubMed ID: 787749 [No Abstract] [Full Text] [Related]
13. The use of pyrithioxine in a group of visually handicapped children. A preliminary report from the School for the Blind, Worcester. Brand HJ S Afr Med J; 1975 May; 49(19):769-73. PubMed ID: 1094565 [TBL] [Abstract][Full Text] [Related]
14. [Acceleration of the action of psychotropic drugs by pyrithioxine]. Pöldinger W; Gehring A; Sutter W Arzneimittelforschung; 1970 Jul; 20(7):936-7. PubMed ID: 5273091 [No Abstract] [Full Text] [Related]
15. Treatment of sensory-neural deafness and tinnitus with a nucleic acid derivative. Makishima K; Yasuda K; Myahara T; Komiyama S; Kato T; Kawata S Arzneimittelforschung; 1971 Sep; 21(9):1343-9. PubMed ID: 4944968 [No Abstract] [Full Text] [Related]
16. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders. Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681 [TBL] [Abstract][Full Text] [Related]
18. [On the psychopharmacotherapy of the brain-damaged child with Encephabol]. Peltz HD Med Welt; 1965 Oct; 43():2438-44. PubMed ID: 5880081 [No Abstract] [Full Text] [Related]